DLTZ

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/13/2016
Contact Info
  • 8655 East Via de Ventura
  • Suite F127
  • Scottsdale, AZ 85258

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001112985
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 1311 - Crude petroleum and natural gas
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1999
Employees 3 a/o Jul 29, 2015
Company Officers/Contacts
Santiago Leopoldo Peralta Interim CEO, President
Kristen L. Magnuson Interim CFO, Consultant
Company Directors
Santiago Leopoldo Peralta
Company Notes
  • Formerly=Delta Mutual, Inc. until 11-2013
  • Note=12-31-04 company is in the development stage
  • Formerly=Helvetia Pharmaceuticals, Inc. until 2-03
  • Formerly=Delta Mutual, Inc. (Old) until 8-02
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States

Legal Counsel
Law Offices of Michael Paige, PLLC
1120 20th Street, NW
South Tower
Washington, D.C., 20036
United States

Investor Relations Firm
Not Available
DLTZ Security Details
Share Structure
Market Value1 $420,405 a/o Dec 08, 2016
Authorized Shares 250,000,000 a/o Sep 30, 2016
Outstanding Shares 32,338,826 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 25,443,583 a/o Dec 31, 2015
Par Value 0.0001
Shareholders
Shareholders of Record 94 a/o Dec 31, 2015
Short Selling Data
Short Interest 0 (-100%)
Jun 30, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security